Elucidating the role of thiol isomerases in platelet function, blood coagulation, and thrombus formation requires understanding how they are packaged and mobilized. 6, 8, 10, [15] [16] [17] [18] [19] In this study, we tracked PDI and ERp57 through development of precursor megakaryocytes and platelets, where we observed that these enzymes are concentrated in a subcellular compartment distinct from known secretory vesicles that overlaps with the dense tubular system (DTS) derived from megakaryocyte smooth ER and with the inner surface of the platelet outer membrane, where the sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) is known to be localized. 20 During platelet activation, actin polymerization facilitates the movement of secretory vesicles to the © 2016 American Heart Association, Inc. Objective-Thiol isomerases facilitate protein folding in the endoplasmic reticulum, and several of these enzymes, including protein disulfide isomerase and ERp57, are mobilized to the surface of activated platelets, where they influence platelet aggregation, blood coagulation, and thrombus formation. In this study, we examined the synthesis and trafficking of thiol isomerases in megakaryocytes, determined their subcellular localization in platelets, and identified the cellular events responsible for their movement to the platelet surface on activation. Approach and Results-Immunofluorescence microscopy imaging was used to localize protein disulfide isomerase and ERp57 in murine and human megakaryocytes at various developmental stages. Immunofluorescence microscopy and subcellular fractionation analysis were used to localize these proteins in platelets to a compartment distinct from known secretory vesicles that overlaps with an inner cell-surface membrane region defined by the endoplasmic/sarcoplasmic reticulum proteins calnexin and sarco/endoplasmic reticulum calcium ATPase 3. Immunofluorescence microscopy and flow cytometry were used to monitor thiol isomerase mobilization in activated platelets in the presence and absence of actin polymerization (inhibited by latrunculin) and in the presence or absence of membrane fusion mediated by Munc13-4 (absent in platelets from Unc13d Jinx mice). Conclusions-Platelet-borne thiol isomerases are trafficked independently of secretory granule contents in megakaryocytes and become concentrated in a subcellular compartment near the inner surface of the platelet outer membrane corresponding to the sarco/endoplasmic reticulum of these cells. Thiol isomerases are mobilized to the surface of activated platelets via a process that requires actin polymerization but not soluble N-ethylmaleimide-sensitive fusion protein attachment receptor/Munc13-4-dependent vesicular-plasma membrane fusion.
T hiol isomerases facilitate the reduction, oxidation, and rearrangement of disulfide bonds essential for correct folding of secreted proteins in the endoplasmic reticulum (ER).
1,2 Some cells also have thiol isomerases in granular structures 3 or at the cell surface, 4, 5 and in platelets, protein disulfide isomerase (PDI), endoplasmic reticulum protein 57 (ERp57), and other thiol isomerases are mobilized to the cell surface with procoagulant activation. Inhibition of plateletborne thiol isomerases reduces aggregation, granule secretion, receptor activation, and thrombus formation in vitro and in vivo. 3, 4, [6] [7] [8] [9] [10] [11] As with platelets, release of thiol isomerases by vascular endothelial cells has been linked to de-encryption of tissue factor, fibrin formation, 10, 12, 13 and neutrophil recruitment to the vessel wall during inflammation. 8 21 where the interaction of soluble N-ethylmaleimide-sensitive fusion protein attachment receptors facilitates membrane fusion mediated by Munc13-4. [22] [23] [24] [25] [26] We observed that surface mobilization of thiol isomerases within activated platelets also requires actin polymerization but proceeds in the absence of Munc13-4-mediated membrane fusion.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Expression and Distribution of PDI and ERp57 During Megakaryocyte Development
Unlike other mammalian cells, platelets are not derived from individual precursors via cell fission. Their development begins in the bone marrow with megakaryocyte progenitors that undergo endomitosis to produce large cells (>20 μm diameter) with multilobed nuclei. Maturing megakaryocytes synthesize large amounts of proteins and develop elaborate intracellular membrane systems. The synthesized secretory cargo (eg, von Willebrand factor [vWF] ) moves from the Golgi to multivesicular bodies (MVBs), where it is joined by endocytosed proteins (eg, fibrinogen) before packaging in secretory granules. The platelet DTS is derived from megakaryocyte smooth ER, whereas cell-surface and open canalicular system membranes originate in the megakaryocyte demarcation membrane system, composed of flattened cisternae and tubules that develop by processes that involve dynamin 2-dependent endocytosis, 27 surface membrane invagination, and PACSIN2-mediated membrane tubulation. 28 Megakaryocyte development culminates in the production of proplatelet extensions that protrude into the vasculature and release hundreds or thousands of platelets from each cell into blood circulation. 29 We examined the intracellular distribution of PDI and ERp57 in developing cultured mouse megakaryocytes via highresolution immunofluorescence microscopy (IFM; Figure 1 ). Megakaryocytes were identified by positive staining for CD41/ integrin αIIb 30 and staged by size, shape, and nuclear morphology. In early (<10 μm diameter) and mitotic cells ( Figure 1A ; Movie I in the online-only Data Supplement), both thiol isomerases were extensively distributed through the cell, a pattern that persisted in later cells (ie, synthetic cells; Figure 1B ; Movie II in the online-only Data Supplement), where ERp57 was sometimes concentrated in perinuclear ribbon-like structures ( Figure 1B , inset detail). Late-stage cultured megakaryocytes typically flatten out before producing proplatelet extensions, and in these extending cells ( Figure 1C ; Movie III in the online-only Data Supplement), both PDI and ERp57 were observed throughout the extranuclear region and in proplatelet extensions ( Figure 1D ; Movie IV in the online-only Data Supplement), including the terminal buds, where PDI seemed to be concentrated near the outer membrane. Although throughout megakaryocyte development colocalization of PDI and ERp57 was observed (white in merged images), substantial proportions of these proteins were not in the same locations. Similar subcellular distributions of these thiol isomerases were observed in cultured human megakaryocytes, where proplatelet development is not as readily observed (data not shown).
Megakaryocyte Trafficking of Thiol Isomerases Is Distinct From Secretory Granules and Cargo
Platelet secretory granule protein cargo is synthesized in the megakaryocyte ER and transported via vesicles derived from the trans-Golgi network 31 to early MVBs, which according to current models also receive cargo in endocytic vesicles as they mature and give rise to platelet lysosomes and α-granules and dense granules. [31] [32] [33] [34] Transferrin receptor (CD71) undergoes clathrin-mediated endocytosis and is frequently used as a marker of the megakaryocyte recycling endocytic compartment, 35 whereas TGN46 is a marker of the trans-Golgi network. IFM examination of thiol isomerase expression in human megakaryocytes in serum-free culture revealed little overlap among ERp57, transferrin receptor, and TGN46 ( Figure 2A ; Movie V in the online-only Data Supplement) or between PDI and the α-granule cargo proteins vWF ( Figure IA and Movie VI in the online-only Data Supplement) and thrombospondin-1 (TSP-1; data not shown). At no point did we observe thiol isomerases distributed in granular puncta (eg, vWF in Figure IA in the online-only Data Supplement) or structures resembling MVBs, rather their distribution pattern was consistent with association with intracellular membranes. Thus, our observations indicate that throughout megakaryocyte and proplatelet development, thiol isomerases are localized in a cellular compartment that is distinct from secretory granules and their cargo and that these enzymes are likely associated with future platelet cell-surface and nongranular membranes.
The trafficking of thiol isomerases within megakaryocytes should determine their distribution within platelets. IFM observations showed consistent association of the α-granule membrane protein P-selectin with cargo proteins (eg, vWF, Figure  IB in the online-only Data Supplement) but not with PDI or ERp57 ( Figure 2B ), which, as observed in megakaryocytes (Figure 1 ), partially overlap with each other (mean Pearson's correlation coefficient=0.6; SD=0.08; n=12 cells). Similar relationships for PDI, ERp57, and P-selectin were observed in platelets from Nbeal2 −/− mice lacking α-granules ( Figure 2C ), and thiol isomerase levels were similar in mouse and human platelets in the presence or absence of α-granules 30, 36 ( Figure 2D and 2E) , further indicating that their production and trafficking is independent of granules and their cargo. The association of thiol isomerases with platelet subcellular structures was investigated by fractionating cell lysates via sucrose gradient ultracentrifugation and then probing fractions via immunoblotting for PDI, ERp57, cell-surface and interior membranes (β3 integrin), proteins associated with cytosol (Rab GDP dissociation inhibitor), α-granule cargo (TSP-1), and the DTS (calreticulin; Figure 3A ). As reported by Jonnalagadda et al, 37 β3 integrin was present in the lighter fractions (2-3), but also abundant in the more dense fractions (8-10); corresponding to the plasma membrane and to the membrane of granules and endosomal compartments, respectively. The soluble cytosolic marker Rab GDP dissociation inhibitor was mainly concentrated at the top of the gradient as were the fractions containing calreticulin, a marker for the DTS previously used to detect PDI in this compartment in platelets. 19 TSP-1 was abundantly expressed in the heaviest fractions where α-granules are fractionated. Consistent with our imaging and previous results, 38 PDI and ERp57 were concentrated in the lightest fractions, indicating association with cell-surface and near-surface membrane structures, such as the DTS. Although fractionation might suggest the presence of thiol isomerases in the platelet cytosol, this is less likely because these proteins are expected to be targeted to the secretory system of cells by virtue of their ER retention motifs (PDI: KDEL and ERp57: QEDL).
We examined the potential interaction of ERp57 with the DTS in human megakaryocyte costained for calnexin, which like thiol isomerases promotes protein folding, 39, 40 but observed little apparent association ( Figure IIA and Movie VII in the online-only Data Supplement). In platelets, we observed that calnexin is associated with well-defined regions distinct from α-granules ( Figure the overlapping regions. Similar results were obtained (data not shown) in colocalization analyses with other markers of the DTS (eg, calreticulin), Golgi (eg, TGN46), and endosomal compartments (eg, EEA1), all of which were confined to intracellular locations distinct from those of thiol isomerases.
The SERCA3 is a well-studied regulator of platelet calcium loading that has been localized to the inner surface of the platelet outer membrane by cell fractionation, immunoprecipitation, and immunoelectron microscopy. 20, 41 The main antibody used in these studies was a mouse monoclonal (PL/ IM430) raised against human platelet membranes that detects all 3 SERCA3 isoforms present in human platelets. 41 Using the same antibody, we examined the relationship of ERp57 with SERCA3 via IFM in human platelets, and the results ( Figure 3B ) show extensive overlap (mean Pearson correlation coefficient=0.794; SD=0.067; n=11 cells) in a compartment near the inner surface of the cell outer membrane delineated by the colocalization of these proteins ( Figure 3 , colocalization channel). Thus, platelet thiol isomerase seems to be concentrated in a compartment that may overlap with the DTS and open canalicular system but is largely located near the inner cell surface.
Platelet-borne PDI has been reported to associate with a T-granule system defined by toll-like receptor 9. 18 We were unable to replicate this observation by IFM with the same antitoll-like receptor 9 antibody used in the original description of the T-granules (data not shown). Consistent with proteomics studies reporting low levels of toll-like receptor 9 in platelets, 42, 43 we could not detect toll-like receptor 9 in platelets by immunoblotting, and consequently, we did not further investigate the presence of thiol isomerases in putative T-granules.
Mobilization of Thiol Isomerases to the Platelet Surface Requires Actin Polymerization but Not Munc13-4-Mediated Membrane Fusion
The SERCA3 interaction partner stromal interaction molecule 1 (STIM1) mobilizes to the surface of activated platelets via a process that is actin dependent and associated with cytoskeletal and microdomain rearrangements but is not thought to involve the fusion of vesicular and cell membranes. 44 Like Figure 2 . Thiol isomerases are not associated with megakaryocyte (MK) trans-Golgi network or recycling endosomal compartments or with platelet α-granules. A, Immunofluorescence microscopy imaging of a representative mature human MK shows ERp57 (green) distributed throughout the cell having little overlap with trans-Golgi defined by TGN46 (red) or recycling endosomes containing transferrin receptor (TFR; magenta; midcell Z-section, bar=10 μm). B, In a human platelet, PDI (green) and ERp57 (red) overlap with each other but not with P-selectin (magenta; midcell Z-sections, bars=1 μm). C, Platelets stained for CD41/integrin αIIb (green), ERp57 (red), and P-selectin (magenta) from wild-type (WT) and Nbeal2 −/− mice (the latter lacking α-granule cargo) show similar intracellular distributions of thiol isomerase (midcell Z-sections, bars=1 μm). D, Immunoblot analysis shows similar levels of PDI and ERp57 in WT and Nbeal2 −/− mouse platelet lysates and (E) similar expression of PDI in lysates from normal human (NH) and Gray platelet syndrome (GPS) patient platelets (actin used as loading control).
other platelet-borne thiol isomerases, PDI and ERp57 move to the surface on activation, 6, 17 as can be observed by IFM comparing their intracellular distribution with that of P-selectin ( Figure IIIA in the online-only Data Supplement). We examined the role of actin polymerization in this process using latrunculin A, which prevents actin polymerization. 45 We determined that 200 μmol/L latrunculin A inhibits P-selectin mobilization in activated platelets by >50% ( Figure IIIB in the online-only Data Supplement), and we compared by IFM the intracellular/extracellular distributions of P-selectin and the α-granule-borne protein vWF ( Figure 4A ) or of P-selectin and thiol isomerases ( Figure 4B ), in platelets activated in the presence or absence of this concentration of latrunculin A. The results show that, in the absence of actin polymerization, platelets underwent little or no mobilization of PDI and ERp57 or of P-selectin and vWF and retained a resting morphology indicated by flat shape and intact tubulin cytoskeletal ring. Using flow cytometry, we observed an increased surface expression of thiol isomerases, as reported previously. 10, 17 Blocking actin polymerization with latrunculin A significantly inhibited the movement to the surface of both PDI and ERp57 ( Figure 4C ).
When platelets are stimulated by agonists, such as protease-activated receptor 4 (PAR4)-activating peptide, Munc13-4 facilitates the pairing of soluble N-ethylmaleimide-sensitive fusion protein attachment receptors 25, 26, 46 involved in the fusion of secretory vesicles with the cell-surface membrane.
Adenosine diphosphate (ADP) has also been observed to trigger Munc13-4-independent granule secretion. 46 We investigated the role of Munc13-4-dependent membrane fusion in platelet thiol isomerase mobilization using Unc13d
Jinx mice, which lack Munc13-4 activity but show equivalent expression to wild-type (WT) of platelet thiol isomerases ( Figure 5A ). Flow cytometry assessment of surface expression of P-selectin and thiol isomerases in resting and agonist-stimulated platelets showed that cells from Unc13d
Jinx mice had significantly less P-selectin surface expression than WT ( Figure 5B ) when stimulated with PAR4-activating peptide, and there was partial rescue of response with ADP. When stimulated with PAR4-activating peptide, Unc13d
Jinx platelets showed greater mobilization of PDI relative to WT (Figure 5B) , and the degree of mobilization was increased in the presence of ADP. These results indicate that Munc13-4-mediated membrane fusion events are not required for the mobilization/release of platelet thiol isomerases during activation, which may involve a mechanism similar to that proposed for STIM1. 44 
Discussion
In this study, we began by tracing the synthesis, trafficking, and packaging of platelet-borne thiol isomerases in cultured primary human and murine megakaryocytes. The use of murine megakaryocytes allowed us to follow platelet development to the proplatelet extension stage, where nascent platelets are loaded with secretory granules and other organelles. This approach has proven effective in elucidating the origin of other platelet proteins, such as glycosyltransferases. 48 Although human megakaryocytes derived from peripherally mobilized CD34 + cells cultured under serum-free conditions do not develop proplatelets as readily as mouse cells, they have also proven useful in studies of the biogenesis of platelet granules. 49 Their use was important to confirm that, as was expected, thiol isomerases destined for platelets are synthesized by megakaryocytes because they are present in cells grown under serum-free conditions and show little evident association with endocytic pathways (Figure 2A ).
Our observations indicate that the bulk of megakaryocyte ERp57 (and most likely PDI) synthesized by megakaryocytes is destined to become platelet cargo ( Figure IIA in the onlineonly Data Supplement), although we did observe an apparent transient strong association of ERp57 with the ER in mouse Figure 4 . Mobilization of thiol isomerases in activated platelets requires actin polymerization. Immunofluorescence microscopy imaging of human platelets activated with 4 μmol/L U46619 in the presence (+LAT) or absence (−LAT) of latrunculin A (LAT) fixed and stained for tubulin (magenta), P-selectin (red), and either (A) CD42b/GP1b (light blue) and von Willebrand factor (vWF; green) or (B) protein disulfide isomerase (PDI; light blue) and ERp57 (green). Reorganization of cytoskeletal tubulin and surface mobilization of P-selectin, vWF, and ERp57 is evident in platelets not treated with latrunculin, whereas treated cells show intracellular protein distribution patterns similar to unactivated platelets ( Figure 2B ). Maximum intensity renders, bars=1 μm. C, The effect of latrunculin treatment on the surface mobilization of thiol isomerases, as compared with that of P-selectin, was quantified by flow cytometry. Platelets were activated with 1 U/mL thrombin, the binding of the primary antibody for thiol isomerases was detected using a fluorescein isothiocyanate-conjugated speciesspecific secondary antibody, the PE/Cy5 antihuman CD62P was used to detect P-selectin. The percentage of inhibition of the median fluorescence intensity was calculated (**P<0.01, 1-way ANOVA, followed by Dunnett test, n=3). Jinx mice shows lack of Munc13-4 in the latter and similar levels of protein disulfide isomerase (PDI) and ERp57 (glyceraldehyde-3-phosphate dehydrogenase [GAPDH] loading control). B, Flow cytometry measurement of median fluorescence intensity (MFI) associated to surface P-selectin (CD62P) and PDI in platelets under resting conditions or after stimulation with PAR4-activating peptide in the presence/absence of ADP shows that P-selectin mobilization is significantly impaired in Unc13d
Jinx platelets, but PDI mobilization is greater than that in WT. ADP significantly increased PDI mobilization as compared with WT or resting Unc13d
Jinx platelets (*P<0.05, *** P<0.001, 1-way ANOVA, followed by Dunnett test or 2-way ANOVA, followed by Bonferroni test, n=4). megakaryocytes undergoing peak protein synthesis ( Figure 1B ). Our observations also consistently indicate that the trafficking of thiol isomerases is distinct from α-granule cargo proteins at all stages of megakaryocyte development, in terms of cellular localization (Figure 1A-1D ; Movies I-IV in the online-only Data Supplement), distribution pattern ( Figure IA and Movie V in the online-only Data Supplement), and interaction with the endocytic and trans-Golgi compartments (Figure 2A ). This indicates that thiol isomerase destined for platelets is not trafficked through the MVBs that process granule-bound cargo. Rather their intracellular distribution indicates association with another of the many megakaryocyte membrane systems, as has been proposed for platelet Golgi-derived glycosyltransferases. 48 The membrane system associated with thiol isomerases seems to elaborate with proplatelet extensions ( Figure 1D ).
In platelets, we observed that consistent with our megakaryocyte observations, PDI and ERp57 are localized in a subcellular compartment distinct from the α-granule matrix delineated by P-selectin ( Figure 2B ). This is consistent with the reported lack of overlap between PDI and lysosomes 50 or hyaluronidase-2 in human platelets, where the latter enzyme has been localized to α-granules via IFM and subcellular fractionation. 51 The thiol isomerase compartment seems to surround the P-selectin matrix ( Figure 2B ) and to be contained by the outer cell membrane ( Figure 2C ), a pattern that holds in gray platelet syndrome human and mouse Nbeal2 −/− platelets where α-granule cargo is absent ( Figure 2C ). The observation that α-granule cargo-deficient platelets have normal levels of thiol isomerases ( Figure 2D and 2E) further supports the independence of their trafficking from granule cargo. Our observations are consistent with reports of thiol isomerase located near the platelet surface 6, 8, 10, [15] [16] [17] and DTS. 19 We saw little association of ERp57 with smooth ER defined by calnexin in mature human megakaryocytes ( Figure IIA in the online-only Data Supplement), although we did observe localized overlap between this marker of the platelet DTS and ERp57 ( Figure IIC in the online-only Data Supplement). According to the most recent proteomics data, ERp57 is approximately twice as abundant as calnexin in platelets (1736 versus 890 ppm 42 ), consistent with our observation that the thiol isomerase is more widely distributed in these cells ( Figure  IIC in the online-only Data Supplement). Subcellular fractionation data indicate that in addition to the DTS, ERp57 and PDI are also likely associated with the cell-surface membrane ( Figure 3A ). This expectation was confirmed by the observation of extensive overlap between ERp57 and SERCA3, long known to be located on the inner surface of the human platelet outer membrane ( Figure 3B) . 20 In addition, ERp57 has been reported to interact with STIM1, 52 a transmembrane ER protein that on calcium depletion translocates to subplasmalemmal punctae, where it interacts with the calcium channel Orai 1 located in the plasma membrane and allows calcium influx are trafficked from the endoplasmic reticulum (ER) via a pathway that leads through the trans-Golgi network to multivesicular bodies. B, Thiol isomerases associate with membranes destined for the platelet dense tubular system (DTS) and cell surface. C, As proplatelet extensions form, secretory cargo proteins are packaged in granules, while thiol isomerases move into forming platelets in association with different membrane structures. D, In mature platelets, thiol isomerases are concentrated near the surface membrane and in the near-surface DTS. E, In activated platelets, actin polymerization and membrane fusion facilitate the surface mobilization and secretion of granule cargo, whereas thiol isomerases mobilized without the need for membrane fusion.
into the cell. 53 Given that as PDI and ERp57, SERCA3 is an ER-derived protein, 20, 41 we cannot exclude the possibility that thiol isomerases codistribute with SERCA3 in a noncalnexin subpopulation of DTS (or possibly ER remnant) that is localized at the inner surface of the platelet membrane.
The mobilization of thiol isomerases to the surface of activated platelets facilitates their involvement in clot formation, [8] [9] [10] and studies have shown that PDI and ERp5 move to the platelet surface with similar kinetics to α-granule proteins. 7 We have extended these observations by demonstrating that as with P-selectin and α-granule cargo, 21 the mobilization of platelet thiol isomerases requires actin polymerization (Figure 4) . Secretion by platelet granules also involves interactions of v-soluble N-ethylmaleimide-sensitive fusion protein attachment receptors present on their surface with t-soluble N-ethylmaleimide-sensitive fusion protein attachment receptors on the plasma membrane, 54, 55 where membrane fusion is primed by Munc13-4, a limiting factor in platelet granule secretion. [22] [23] [24] 26 We observed that compared with WT mice, platelet thiol isomerase mobilization is stronger in Unc13d Jinx mice, where platelets lack Munc13-4 activity and have absent or severely impaired P-selectin mobilization ( Figure 5B ) and secretion from lysosomes and dense and α-granules, although they do show activation-associated changes in morphology. 25 We also observed that thiol isomerase mobilization is enhanced in both mutant and WT mouse platelets by ADP, which has been shown to stimulate Munc13-4-independent secretion of α-granule contents. 46 Thus, our observations indicate that although platelet thiol isomerase mobilization/ secretion requires actin polymerization, it does not involve Munc13-4-mediated membrane fusion. It may be that the cellular rearrangements associated with platelet activation are sufficient to move thiol isomerases to the surface and facilitate their release, as has been proposed for STIM1. 56 Increased surface exposure of PDI in the absence of Munc13-4 could also indicate that this protein serves as a brake on the mobilization of platelet thiol isomerases, pointing to a novel aspect of regulation of platelet function.
The results presented here can be combined with current knowledge to produce a model of platelet thiol isomerase trafficking, packaging, and mobilization in activated cells. In this scheme (Figure 6 ; for the sake of simplicity only megakaryocyte-synthesized proteins are considered), protein destined for platelet α-granules (eg, vWF, TSP-1) moves from the megakaryocyte ER to the trans-Golgi network for sorting into MVBs that give rise to mature secretory vesicles. Following a different route, thiol isomerases destined for platelets move from the ER to the developing intracellular membranes. When megakaryocytes extend proplatelets, secretory cargo is packaged into granules, whereas thiol isomerases associate with membranes that give rise to the platelet surface and possibly the outer DTS and open canalicular system. In platelets that later undergo activation, thiol isomerases are mobilized to the outer cell surface via a mechanism driven by actin polymerization and cytoskeletal/membrane rearrangements.
Elucidation of the expression and function of platelet thiol isomerases is important because these enzymes have been shown to be key modulators of thrombus formation via their activity on the surface of platelets and vascular endothelial cells. The influence of PDI, ERp57, and ERp5 on platelet function has been primarily attributed to their ability to bind the platelet cell-surface receptor integrin αIIbβ3 and thus favor its activation, [6] [7] [8] [9] [10] and it is also likely that this receptor assumes a high-affinity conformation in activated platelets that facilitates surface binding of mobilized PDI and ERp57. 57 A search for other substrates of thiol isomerases is ongoing, as are efforts to develop methods for the selective modulation of thiol isomerases as a therapeutic strategy against thrombotic disease.
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